The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India.Applied health economics and health policy · 2021
   Pooled it
2. Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012-2024).Lancet regional health. Americas · 2026
   Article
3. Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual framework.International journal for equity in health · 2025
   Review
4. The role of budget impact in reimbursement decisions in The Netherlands: interviews with decision-makers and pharmaceutical industry representatives.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
   Article
5. Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions.Applied health economics and health policy · 2025
   Review
6. Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
   Article
7. The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
   Article
8. The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium.Journal of market access & health policy · 2024
   Article
9. Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs.Cost effectiveness and resource allocation : C/E · 2023
   Article
10. A symptomatic approach to tuberculosis screening for high-risk groups in Malaysia: Cost-effectiveness and budget impact analysis.Journal of clinical tuberculosis and other mycobacterial diseases · 2022
    Article
11. The evolution of ICER's review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improve the quality of evidence in ICER's reports.Journal of managed care & specialty pharmacy · 2021
    Article
12. Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries.Applied health economics and health policy · 2021
    Review
13. Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria.Frontiers in pharmacology · 2021
    Article
14. Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review.Frontiers in pharmacology · 2021
    Review
15. Affordability of oncology drugs: accuracy of budget impact estimations.Journal of market access & health policy · 2020
    Article
16. Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study.The European journal of health economics : HEPAC : health economics in prevention and care · 2019
    Article
17. Integrating a brief mental health intervention into primary care services for patients with HIV and diabetes in South Africa: study protocol for a trial-based economic evaluation.BMJ open · 2019
    Article
18. The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).PharmacoEconomics · 2018
    Review
19. A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions.ClinicoEconomics and outcomes research : CEOR · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as